Recipient and donor age impact the risk of developing chronic GvHD in children after allogeneic hematopoietic transplant

B K Watkins¹, J Horan¹, B Storer^{2

3}, P J Martin^{2

4}, P A Carpenter^{2

5}, M E D Flowers^{2

4}

Affiliations

¹ Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University, Atlanta, GA, USA.
² Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
³ Department of Biostatistics, University of Washington School of Medicine, Seattle, WA, USA.
⁴ Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
⁵ Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA.

B K Watkins et al. Bone Marrow Transplant. 2017 Apr.

. 2017 Apr;52(4):625-626.

doi: 10.1038/bmt.2016.328. Epub 2016 Dec 19.

B K Watkins¹, J Horan¹, B Storer^{2

3}, P J Martin^{2

4}, P A Carpenter^{2

5}, M E D Flowers^{2

4}

¹ Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University, Atlanta, GA, USA.
² Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
³ Department of Biostatistics, University of Washington School of Medicine, Seattle, WA, USA.
⁴ Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
⁵ Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA.

No abstract available

References